Overview
Brian Yirinec is an Oncologist in Rochester, New York. Dr. Yirinec is highly rated in 13 conditions, according to our data. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- MEDICARE SNP
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
125 Red Creek Dr, Rochester, NY 14623
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Francisco Hernandez is an Oncologist in Buffalo, New York. Dr. Hernandez is highly rated in 28 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Gastrostomy.
University Of Rochester
Deborah Mulford is an Oncologist in Rochester, New York. Dr. Mulford is highly rated in 11 conditions, according to our data. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Squamous Cell Lung Carcinoma.
Office
Ruth O'regan is an Oncologist in Rochester, New York. Dr. O'regan is highly rated in 7 conditions, according to our data. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Tissue Biopsy.
Frequently Asked Questions about Dr. Brian Yirinec
How do I make an appointment with Dr. Brian Yirinec?
You can book an appointment with Dr. Brian Yirinec by calling their office at 585-486-0600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Brian Yirinec a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Brian Yirinec is classified as an Distinguished expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Brian Yirinec specialize in?
While Dr. Brian Yirinec is a Oncology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Brian Yirinec participate in research or clinical trials?
Yes. Dr. Brian Yirinec has published 1 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Brian Yirinec's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Brian Yirinec accept my insurance?
Dr. Brian Yirinec accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 585-486-0600 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Yirinec isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung AdenocarcinomaDr. Yirinec isDistinguished. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Dr. Yirinec isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Yirinec isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- AngiosarcomaDr. Yirinec isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Yirinec isAdvanced. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Yirinec isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Colorectal CancerDr. Yirinec isAdvanced. Learn about Familial Colorectal Cancer.
- Inflammatory Breast CancerDr. Yirinec isAdvanced. Learn about Inflammatory Breast Cancer.
- Large-Cell Lung CarcinomaDr. Yirinec isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Experienced
- Acute Mountain SicknessDr. Yirinec isExperienced. Learn about Acute Mountain Sickness.
- Bone TumorDr. Yirinec isExperienced. Learn about Bone Tumor.
- Breast Cancer in MenDr. Yirinec isExperienced. Learn about Breast Cancer in Men.
- Carcinoid SyndromeDr. Yirinec isExperienced. Learn about Carcinoid Syndrome.
- Castleman DiseaseDr. Yirinec isExperienced. Learn about Castleman Disease.
- Childhood Acute Myeloid LeukemiaDr. Yirinec isExperienced. Learn about Childhood Acute Myeloid Leukemia.